PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 57 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,000 | – | 437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management III, LLC | 722,890 | $911,000 | 0.53% |
| GREAT POINT PARTNERS LLC | 3,500,000 | $4,410,000 | 0.44% |
| NEA Management Company, LLC | 5,556,778 | $7,002,000 | 0.36% |
| SECTORAL ASSET MANAGEMENT INC | 2,050,328 | $2,583,000 | 0.31% |
| HARBOURVEST PARTNERS LLC | 440,627 | $555,000 | 0.20% |
| VHCP Management II, LLC | 427,110 | $538,000 | 0.16% |
| Endurant Capital Management LP | 130,600 | $165,000 | 0.06% |
| ALGERT GLOBAL LLC | 64,300 | $81,000 | 0.05% |
| Bain Capital Public Equity Management, LLC | 231,418 | $292,000 | 0.03% |
| Kazazian Asset Management, LLC | 14,436 | $18,000 | 0.02% |